Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.L'invention concerne des composés qui inhibent le RET de type sauvage et ses mutants résistants, des compositions pharmaceutiques comprenant lesdits composés, et des procédés d'utilisation desdits composés et desdites compositions.